CareCloud's Preferred Stock Proposal Gains Strong Support
CareCloud, Inc. (NASDAQ: CCLD, CCLDO, CCLDP), a prominent provider of healthcare technology solutions, has announced a notable surge in support for its Series A Preferred Stock proposal. With an impressive 89% of proxy votes cast in favor, the Company is set to reconvene its Special Meeting for further discussions.
Upcoming Special Meeting Details
Due to the positive feedback from shareholders, the Special Meeting will be rescheduled shortly. CareCloud's President, Stephen Snyder, expressed excitement about the strong backing from investors, highlighting that nearly 9 out of 10 shareholders who responded voted in favor of the proposal. This comes after a favorable recommendation from proxy advisory firm Glass Lewis, which increases the chances of a successful outcome.
How Shareholders Can Vote
Shareholders who wish to cast their votes have several options: they can vote by phone, online, or by mailing in their completed proxy cards. Investors are encouraged to participate actively to ensure their opinions are represented in the upcoming meeting. For those planning to attend in person, detailed instructions can be found in the Definitive Proxy materials provided by CareCloud.
What the Preferred Stock Proposal Means
If the proposal is approved, holders of Series A Preferred Stock will receive additional protections similar to those enjoyed by holders of the Company’s Series B 8.75% Cumulative Redeemable Perpetual Preferred Stock. Furthermore, dividends on the Series A shares will align with those of the Series B shares, and shareholders may also have the option to exchange Series A shares for common stock at a price of $25 per share, plus any accrued dividends.
Investor Outlook and Future Challenges
While the Company is optimistic about securing the necessary votes for the proposal's approval, it remains realistic about the potential challenges that lie ahead. Any shares that do not receive votes will be counted as “no” votes, which poses a greater challenge in achieving the two-thirds majority required for approval. The focus now is on encouraging shareholders to engage actively in the voting process.
About CareCloud
CareCloud is a leader in healthcare technology innovation. The Company offers a comprehensive suite of solutions aimed at improving operational efficiency and enhancing patient experiences for healthcare providers. With a growing client base of over 40,000 providers, CareCloud is committed to streamlining clinical workflows while reducing administrative burdens and costs.
Overview of Core Offerings and Services
CareCloud provides a wide array of services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management, and digital health solutions. This extensive range allows CareCloud to effectively address the evolving needs of the healthcare ecosystem.
Frequently Asked Questions
What is the current voting percentage for the Preferred Stock Proposal?
Approximately 89% of the shares represented by proxies returned indicated a vote of “FOR” the proposal.
When is the Special Meeting for the Preferred Stock Proposal?
The Special Meeting is scheduled to be reconvened soon, with specific details to be announced shortly.
How can shareholders vote on the proposal?
Shareholders can submit their voting instructions by calling 844-874-6164 or by visiting the designated proxy voting website.
What are the benefits if the Preferred Stock Proposal is approved?
Approval would provide holders of Series A shares with similar protections as Series B holders and allow for a share exchange at a predetermined value.
Who should shareholders contact for further information?
Shareholders can reach out to Norman Roth, the Interim Chief Financial Officer, at nroth@carecloud.com for any inquiries regarding the proposal.
